T-cell Co-inhibitory Molecules in Sepsis-induced Immunosuppression: From Bench to Bedside

Chin Med J (Engl). 2017 May 20;130(10):1249-1252. doi: 10.4103/0366-6999.205867.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity / immunology
  • Animals
  • CTLA-4 Antigen / metabolism
  • Humans
  • Immunosuppression Therapy
  • Intensive Care Units
  • Programmed Cell Death 1 Receptor / metabolism
  • Sepsis / immunology*
  • Sepsis / metabolism

Substances

  • CTLA-4 Antigen
  • Programmed Cell Death 1 Receptor